Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HRTX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HRTX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Heron Therapeutics, Inc. /DE/(HRTX US)

$0.28-0.013.56%(Market Open · 19:42:55 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Heron Therapeutics, Inc. /DE/(HRTX US)

$0.28-0.013.56%(Market Open · 19:42:55 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(135)

Expand
  • 10-QQ2ended 30 Jun 202610 Aug
  • 10-QQ1ended 31 Mar 202611 May
  • 10-KFY 2025ended 31 Dec 202526 Feb
  • 10-QQ3ended 30 Sept 20254 Nov 2025
  • 10-QQ2ended 30 Jun 20258 Aug 2025
  • 10-QQ1ended 31 Mar 20256 May 2025
  • 10-KFY 2024ended 31 Dec 202427 Feb 2025
  • 10-QQ3ended 30 Sept 202412 Nov 2024
  • 10-QQ2ended 30 Jun 20246 Aug 2024
  • 10-QQ1ended 31 Mar 20247 May 2024
  • 10-KFY 2023ended 31 Dec 202312 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023
  • 10-QQ1ended 31 Mar 202311 May 2023
  • 10-KFY 2022ended 31 Dec 202229 Mar 2023

Events(342)

Expand
  • 8-KEntry into a Material Definitive Agreement29 Sep
  • 8-KEntry into a Material Definitive Agreement14 Aug
  • 8-KResults of Operations and Financial Condition10 Aug
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing25 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders16 Jun
  • 8-KOther Events2 Jun
  • 8-KResults of Operations and Financial Condition11 May
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers6 Apr
  • 8-KResults of Operations and Financial Condition26 Feb
  • 8-KRegulation FD Disclosure9 Jan
  • 8-KResults of Operations and Financial Condition4 Nov 2025
  • 8-KDirector/Officer Changes & Compensatory Arrangements29 Oct 2025
  • 8-KSubmission of Matters to Shareholder Vote15 Oct 2025
  • 8-KEntry into Material Agreement28 Aug 2025
  • 8-KEntry into Material Agreement15 Aug 2025

Insider Ownership(584)

Expand
  • 4Statement of changes in beneficial ownership12:57PM
  • 4Statement of changes in beneficial ownership12:54PM
  • 4Statement of changes in beneficial ownership12:53PM
  • 4Statement of changes in beneficial ownership12:50PM
  • 4Statement of changes in beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership10 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership20 Jul
  • 4Statement of changes in beneficial ownership20 Jul
  • 4Statement of changes in beneficial ownership20 Jul

Beneficial Ownership(218)

Expand
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/13 May
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/27 Mar
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/17 Feb
  • SC 13GHERON THERAPEUTICS, INC. /DE/30 Jan
  • SC 13GHERON THERAPEUTICS, INC. /DE/26 Nov 2025
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/30 Oct 2025
  • SC 13D/AHERON THERAPEUTICS, INC. /DE/17 Oct 2025
  • SC 13D/AHERON THERAPEUTICS, INC. /DE/12 Aug 2025
  • SC 13GHERON THERAPEUTICS, INC. /DE/12 Nov 2024
  • SC 13GHERON THERAPEUTICS, INC. /DE/8 Nov 2024
  • SC 13GHERON THERAPEUTICS, INC. /DE/24 Oct 2024
  • SC 13D/AHERON THERAPEUTICS, INC. /DE/31 May 2024
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/14 Feb 2024
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/14 Feb 2024
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/14 Feb 2024

Other Ownership(9)

Expand
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun 2004
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun 2003
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)28 Jun 2002
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)27 Jun 2001
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2000
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)15 Jun 1999
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)30 Mar 1998
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)31 Mar 1997
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Mar 1996

Proxies(68)

Expand
  • ARSAnnual report to security holders30 Apr
  • DEFA14ADefinitive additional materials30 Apr
  • DEF 14ADefinitive proxy statement30 Apr
  • PRE 14APreliminary proxy statement20 Apr
  • DEF 14ADefinitive proxy statement19 Sep 2025
  • PRE 14APreliminary proxy statement9 Sep 2025
  • DEFA14ADefinitive additional materials30 Apr 2025
  • DEF 14ADefinitive proxy statement30 Apr 2025
  • ARSAnnual report to security holders30 Apr 2025
  • ARSAnnual report to security holders29 Apr 2024
  • DEF 14ADefinitive proxy statement29 Apr 2024
  • PRE 14APreliminary proxy statement19 Apr 2024
  • ARSAnnual report to security holders1 May 2023
  • DEF 14ADefinitive proxy statement1 May 2023
  • PRE 14APreliminary proxy statement20 Apr 2023

Registrations(104)

Expand
  • S-8Registration statement (employee benefit plan)27 Oct
  • S-3Registration statement (primary offering)9 Sep 2025
  • S-3Registration statement (primary offering)9 Sep 2025
  • 8-A12BRegistration of securities (Section 12(b))15 Aug 2025
  • S-8Registration statement (employee benefit plan)6 May 2025
  • S-8Registration statement (employee benefit plan)6 Aug 2024
  • 424B3Prospectus filing (Rule 424(b)(3))6 Sep 2023
  • S-3Registration statement (primary offering)23 Aug 2023
  • S-8Registration statement (employee benefit plan)30 Jun 2023
  • 424B5Prospectus filing (Rule 424(b)(5))20 Oct 2022
  • S-3Registration statement (primary offering)7 Oct 2022
  • S-8Registration statement (employee benefit plan)9 Sep 2022
  • S-8Registration statement (employee benefit plan)14 Sep 2021
  • S-3ASRAutomatic shelf registration statement (S-3)28 May 2021
  • 424B2Prospectus filing (Rule 424(b)(2))7 Oct 2019

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence12 Sep 2025
  • CORRESPFiling review correspondence12 Sep 2025
  • CORRESPFiling review correspondence30 Aug 2023
  • CORRESPFiling review correspondence13 Oct 2022
  • CORRESPFiling review correspondence10 Aug 2021
  • CORRESPFiling review correspondence30 Jul 2018
  • CORRESPFiling review correspondence6 Feb 2006
  • UPLOADFiling review upload2 Feb 2006
  • UPLOADFiling review upload23 Nov 2005
  • CORRESPFiling review correspondence15 Nov 2005
  • UPLOADFiling review upload31 Oct 2005

SEC Orders And Notices(19)

Expand
  • EFFECTNotice of effectiveness16 Sep 2025
  • EFFECTNotice of effectiveness16 Sep 2025
  • EFFECTNotice of effectiveness31 Aug 2023
  • EFFECTNotice of effectiveness18 Oct 2022
  • CT ORDERConfidential treatment order30 Jan 2017
  • CT ORDERConfidential treatment order28 Dec 2016
  • CT ORDERConfidential treatment order7 Jul 2015
  • EFFECTNotice of effectiveness6 Oct 2014
  • EFFECTNotice of effectiveness23 May 2014
  • EFFECTNotice of effectiveness26 Aug 2013
  • EFFECTNotice of effectiveness6 Sep 2012
  • EFFECTNotice of effectiveness2 Apr 2012
  • EFFECTNotice of effectiveness2 Apr 2012
  • EFFECTNotice of effectiveness4 Aug 2011
  • EFFECTNotice of effectiveness29 Jul 2011

Exempt Offerings(5)

Expand
  • D06b1 Aug 2023
  • DNotice of exempt offering of securities (Reg D)10 Aug 2012
  • DNotice of exempt offering of securities (Reg D)11 Jul 2011
  • DNotice of exempt offering of securities (Reg D)13 May 2011
  • DNotice of exempt offering of securities (Reg D)5 Nov 2009

Other(4)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT22 Jan 2014
  • 10-C10-C29 Mar 1996
  • 10-K40510-K40527 Mar 1996
  • 10-C10-C4 May 1995

Financials(135)

Expand
  • 10-QQ2ended 30 Jun 202610 Aug
  • 10-QQ1ended 31 Mar 202611 May
  • 10-KFY 2025ended 31 Dec 202526 Feb
  • 10-QQ3ended 30 Sept 20254 Nov 2025
  • 10-QQ2ended 30 Jun 20258 Aug 2025
  • 10-QQ1ended 31 Mar 20256 May 2025
  • 10-KFY 2024ended 31 Dec 202427 Feb 2025
  • 10-QQ3ended 30 Sept 202412 Nov 2024
  • 10-QQ2ended 30 Jun 20246 Aug 2024
  • 10-QQ1ended 31 Mar 20247 May 2024
  • 10-KFY 2023ended 31 Dec 202312 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023
  • 10-QQ1ended 31 Mar 202311 May 2023
  • 10-KFY 2022ended 31 Dec 202229 Mar 2023

Events(342)

Expand
  • 8-KEntry into a Material Definitive Agreement29 Sep
  • 8-KEntry into a Material Definitive Agreement14 Aug
  • 8-KResults of Operations and Financial Condition10 Aug
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing25 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders16 Jun
  • 8-KOther Events2 Jun
  • 8-KResults of Operations and Financial Condition11 May
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers6 Apr
  • 8-KResults of Operations and Financial Condition26 Feb
  • 8-KRegulation FD Disclosure9 Jan
  • 8-KResults of Operations and Financial Condition4 Nov 2025
  • 8-KDirector/Officer Changes & Compensatory Arrangements29 Oct 2025
  • 8-KSubmission of Matters to Shareholder Vote15 Oct 2025
  • 8-KEntry into Material Agreement28 Aug 2025
  • 8-KEntry into Material Agreement15 Aug 2025

Insider Ownership(584)

Expand
  • 4Statement of changes in beneficial ownership12:57PM
  • 4Statement of changes in beneficial ownership12:54PM
  • 4Statement of changes in beneficial ownership12:53PM
  • 4Statement of changes in beneficial ownership12:50PM
  • 4Statement of changes in beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership10 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership3 Aug
  • 4Statement of changes in beneficial ownership20 Jul
  • 4Statement of changes in beneficial ownership20 Jul
  • 4Statement of changes in beneficial ownership20 Jul

Beneficial Ownership(218)

Expand
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/13 May
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/27 Mar
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/17 Feb
  • SC 13GHERON THERAPEUTICS, INC. /DE/30 Jan
  • SC 13GHERON THERAPEUTICS, INC. /DE/26 Nov 2025
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/30 Oct 2025
  • SC 13D/AHERON THERAPEUTICS, INC. /DE/17 Oct 2025
  • SC 13D/AHERON THERAPEUTICS, INC. /DE/12 Aug 2025
  • SC 13GHERON THERAPEUTICS, INC. /DE/12 Nov 2024
  • SC 13GHERON THERAPEUTICS, INC. /DE/8 Nov 2024
  • SC 13GHERON THERAPEUTICS, INC. /DE/24 Oct 2024
  • SC 13D/AHERON THERAPEUTICS, INC. /DE/31 May 2024
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/14 Feb 2024
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/14 Feb 2024
  • SC 13G/AHERON THERAPEUTICS, INC. /DE/14 Feb 2024

Other Ownership(9)

Expand
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun 2004
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun 2003
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)28 Jun 2002
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)27 Jun 2001
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2000
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)15 Jun 1999
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)30 Mar 1998
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)31 Mar 1997
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Mar 1996

Proxies(68)

Expand
  • ARSAnnual report to security holders30 Apr
  • DEFA14ADefinitive additional materials30 Apr
  • DEF 14ADefinitive proxy statement30 Apr
  • PRE 14APreliminary proxy statement20 Apr
  • DEF 14ADefinitive proxy statement19 Sep 2025
  • PRE 14APreliminary proxy statement9 Sep 2025
  • DEFA14ADefinitive additional materials30 Apr 2025
  • DEF 14ADefinitive proxy statement30 Apr 2025
  • ARSAnnual report to security holders30 Apr 2025
  • ARSAnnual report to security holders29 Apr 2024
  • DEF 14ADefinitive proxy statement29 Apr 2024
  • PRE 14APreliminary proxy statement19 Apr 2024
  • ARSAnnual report to security holders1 May 2023
  • DEF 14ADefinitive proxy statement1 May 2023
  • PRE 14APreliminary proxy statement20 Apr 2023

Registrations(104)

Expand
  • S-8Registration statement (employee benefit plan)27 Oct
  • S-3Registration statement (primary offering)9 Sep 2025
  • S-3Registration statement (primary offering)9 Sep 2025
  • 8-A12BRegistration of securities (Section 12(b))15 Aug 2025
  • S-8Registration statement (employee benefit plan)6 May 2025
  • S-8Registration statement (employee benefit plan)6 Aug 2024
  • 424B3Prospectus filing (Rule 424(b)(3))6 Sep 2023
  • S-3Registration statement (primary offering)23 Aug 2023
  • S-8Registration statement (employee benefit plan)30 Jun 2023
  • 424B5Prospectus filing (Rule 424(b)(5))20 Oct 2022
  • S-3Registration statement (primary offering)7 Oct 2022
  • S-8Registration statement (employee benefit plan)9 Sep 2022
  • S-8Registration statement (employee benefit plan)14 Sep 2021
  • S-3ASRAutomatic shelf registration statement (S-3)28 May 2021
  • 424B2Prospectus filing (Rule 424(b)(2))7 Oct 2019

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence12 Sep 2025
  • CORRESPFiling review correspondence12 Sep 2025
  • CORRESPFiling review correspondence30 Aug 2023
  • CORRESPFiling review correspondence13 Oct 2022
  • CORRESPFiling review correspondence10 Aug 2021
  • CORRESPFiling review correspondence30 Jul 2018
  • CORRESPFiling review correspondence6 Feb 2006
  • UPLOADFiling review upload2 Feb 2006
  • UPLOADFiling review upload23 Nov 2005
  • CORRESPFiling review correspondence15 Nov 2005
  • UPLOADFiling review upload31 Oct 2005

SEC Orders And Notices(19)

Expand
  • EFFECTNotice of effectiveness16 Sep 2025
  • EFFECTNotice of effectiveness16 Sep 2025
  • EFFECTNotice of effectiveness31 Aug 2023
  • EFFECTNotice of effectiveness18 Oct 2022
  • CT ORDERConfidential treatment order30 Jan 2017
  • CT ORDERConfidential treatment order28 Dec 2016
  • CT ORDERConfidential treatment order7 Jul 2015
  • EFFECTNotice of effectiveness6 Oct 2014
  • EFFECTNotice of effectiveness23 May 2014
  • EFFECTNotice of effectiveness26 Aug 2013
  • EFFECTNotice of effectiveness6 Sep 2012
  • EFFECTNotice of effectiveness2 Apr 2012
  • EFFECTNotice of effectiveness2 Apr 2012
  • EFFECTNotice of effectiveness4 Aug 2011
  • EFFECTNotice of effectiveness29 Jul 2011

Exempt Offerings(5)

Expand
  • D06b1 Aug 2023
  • DNotice of exempt offering of securities (Reg D)10 Aug 2012
  • DNotice of exempt offering of securities (Reg D)11 Jul 2011
  • DNotice of exempt offering of securities (Reg D)13 May 2011
  • DNotice of exempt offering of securities (Reg D)5 Nov 2009

Other(4)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT22 Jan 2014
  • 10-C10-C29 Mar 1996
  • 10-K40510-K40527 Mar 1996
  • 10-C10-C4 May 1995